Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Published online before print April 16, 2008, doi:10.1212/01.wnl.0000304372.01248.02)
This Article
Right arrow Full Text (Rapid PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
01.wnl.0000304372.01248.02v1
70/22/2053    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wermer, M. J.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wermer, M. J.H.
Received April 12, 2007
Accepted October 18, 2007

Effectiveness and costs of screening for aneurysms every 5 years after subarachnoid hemorrhage

Marieke J.H. Wermer MD*, Hendrik Koffijberg MSc, Irene C. van der Schaaf MD, For the ASTRA Study Group

From the Departments of Neurology, Neurosurgery and Radiology of the University Medical Center Utrecht and the Academic Medical Center Amsterdam and the Julius Center for Health Sciences and Primary Care Utrecht, The Netherlands.


* To whom correspondence should be addressed. E-mail: m.wermer{at}umcutrecht.nl.

Background: Patients who survive after subarachnoid hemorrhage (SAH) are at risk for a recurrence despite successful treatment of the ruptured aneurysm and may therefore benefit from screening for new aneurysms.

Methods: We screened 610 patients with SAH with CT angiography 2–18 years after clipping of the aneurysms. Results of screening were used as input for a Markov decision model. We compared the expected number of recurrent hemorrhages, life expectancy, quality-adjusted life-years (QALYs), and costs associated with the strategies "screening every 5 years" and "no screening."

Results: Screening individuals with previous SAH prevented almost half of the recurrences, slightly increased life expectancy (from 21.06 to 21.08 years), but reduced QALYs (from 12.18 to 12.04) and increased costs (from $2,750 to $4,165 per patient). Screening was cost-saving without increasing QALYs in patients with a more than twofold risk above baseline of both aneurysm formation and rupture and it was cost-saving while increasing QALYs if both risks were at least 4.5 times higher. In patients with reduced quality of life because of fear for a recurrence, screening increased QALYs at a maximum cost of $17,422 per QALY.

Conclusions: In general, screening patients with previous subarachnoid hemorrhage (SAH) cannot be recommended. Screening can save costs and increase quality-adjusted life-years (QALYs) in patients with a relatively high risk of both aneurysm formation and rupture, and increases QALYs at acceptable costs in patients with fear for a recurrence. More data are needed on risk factors for aneurysm formation and rupture in patients with previous SAH and on management of fear for a recurrence to identify patients who can benefit from screening.




This article has been cited by other articles:


Home page
 Am. J. Neuroradiol.Home page
W.J. van Rooij and M. Sluzewski
Opinion: Imaging Follow-Up after Coiling of Intracranial Aneurysms
AJNR Am. J. Neuroradiol., October 1, 2009; 30(9): 1646 - 1648.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
J. Raymond
Counterpoint: Has the Last Word Been Said?
AJNR Am. J. Neuroradiol., October 1, 2009; 30(9): 1649 - 1652.
[Full Text] [PDF]

Home page
 NeurologyHome page
J. P. Greving, G. J.E. Rinkel, E. Buskens, and A. Algra
Cost-effectiveness of preventive treatment of intracranial aneurysms: New data and uncertainties
Neurology, July 28, 2009; 73(4): 258 - 265.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. C. Torner, N. C. Bambakidis, R. W. Tarr, and W. R. Selman
Choosing a treatment for unruptured aneurysms
Neurology, July 28, 2009; 73(4): 254 - 255.
[Full Text] [PDF]

Home page
 StrokeHome page
J. D. Schaafsma, M. E. Sprengers, W. J. van Rooij, M. Sluzewski, C. B.L.M. Majoie, M. J.H. Wermer, and G. J.E. Rinkel
Long-Term Recurrent Subarachnoid Hemorrhage After Adequate Coiling Versus Clipping of Ruptured Intracranial Aneurysms
Stroke, May 1, 2009; 40(5): 1758 - 1763.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
M.E. Sprengers, W.J. van Rooij, M. Sluzewski, G.J.E. Rinkel, B.K. Velthuis, G.A.P. de Kort, and C.B.L.M. Majoie
MR Angiography Follow-Up 5 Years after Coiling: Frequency of New Aneurysms and Enlargement of Untreated Aneurysms
AJNR Am. J. Neuroradiol., February 1, 2009; 30(2): 303 - 307.
[Abstract] [Full Text] [PDF]

Home page
 Med Decis MakingHome page
H. Koffijberg, G. Rinkel, and E. Buskens
Do Intraindividual Variation in Disease Progression and the Ensuing Tight Window of Opportunity Affect Estimation of Screening Benefits?
Med Decis Making, January 1, 2009; 29(1): 82 - 90.
[Abstract] [PDF]

Home page
 NeurologyHome page
D. C. Spencer
The state of the art of medicine: Deciding on preventive screening tests after bleeding in the brain
Neurology, May 27, 2008; 70(22): e92 - e94.
[Full Text] [PDF]

Home page
 NeurologyHome page
D. B. Zahuranec and L. B. Morgenstern
Fear factor: Aneurysm screening after subarachnoid hemorrhage
Neurology, May 27, 2008; 70(22): 2022 - 2023.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by AAN Enterprises, Inc.